ORIGINAL ARTICLE |
|
Year : 2016 | Volume
: 16
| Issue : 3 | Page : 185-191 |
|
Ultrasound-guided platelet-rich plasma infiltration: A stupendous treatment for chronic tendinopathy
Abhijeet Sahu1, Pradeep K Singh2, Sohael Khan1, Shraddha Singhania3, Mahendra Gudhe1, Gaurav Mundada1, Vasant Gawande1
1 Department of Orthopaedics, Jawaharlal Nehru Medical College, Wardha, India 2 Department of Orthopaedics (Spine), Hiranandani Hospital, Mumbai, Maharashtra, India 3 Department of Radiodiagnosis, Datta Meghe Institute of Medical Sciences, Wardha, India
Correspondence Address:
Sohael Khan C/O Dr. M. J. Khan, Shishu Hospital, Opp. Zilla Parishad, Sarai Ward, Chandrapur - 442 401, Maharashtra India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/1319-6308.191334
|
|
Background: Tendinopathy is a common and perplexing problem facing clinicians. It is the most common reason that patients seek medical attention for a musculoskeletal condition and accounts for approximately 30% of patient visits to general practitioners. Although originally considered an inflammatory problem, histopathologic analysis of tendinopathy has revealed evidence that this process is predominantly degenerative and is characterized by hypercellularity, vascular hyperplasia, and collagen disorganization. Since tendinopathy is primarily a degenerative condition, several new treatments have been developed in an attempt to stimulate tissue regeneration. One of these treatments is an injection of platelet-rich plasma (PRP). Materials and Methods: This is a prospective study conducted in the Department of Orthopaedics on outpatients having tendinopathies. These patients were managed with PRP infiltration at the tendinopathy site. Current proposed sample size in the study is sixty patients between the age of 21 and 65 years. The patients who are clinically diagnosed were given PRP at the tendinopathy after identifying the site under ultrasound guidance. Patients were assessed according to the visual analog scale (VAS) and Disabilities of the Arm, Shoulder, and Hand (DASH) score pre- and post-injection. Results: Patients in the fourth decade had major preponderance. Male gender was dominant with the problem of tendinopathies. Supraspinatus tendinopathy was most common among all tendinopathies. Comparison of VAS with each follow-up showed 22.5% decrease in 1 st week and 58.58% relief in 4 th week. After evaluation using DASH score, there was 7.23% improvement in 1 st week, 12.43% in 4 th week, and 57.63% in 24 th week. Conclusion: The current investigation represents clinically based outcome study to evaluate the effectiveness of treating tendinopathy with ultrasonography-guided PRP injection. There is reduced the risk of infection, better improvement regarding pain, restoration of mobility, and duration of time required for clinical improvement. None of these patients reported with the recurrence of symptoms when followed up after 6 months of treatment. |
|
|
|
[FULL TEXT] [PDF]* |
|
 |
|